Robert J Deluccia, a major owner of Dipexium Pharmaceuticals, Inc. and Dipexium Pharmaceuticals, Inc.'s Executive Chairman and a director of the company, just received 183,332 options from the company. The strike price of the options received was $1.80, and these expire on January 17, 2022. Deluccia now owns at least 183,332 options on the company.
Some additional info was provided as follows:
Options to purchase shares of common stock vest as follows: options to purchase 91,666 shares of common stock vested on January 17, 2017; options to purchase 3,819 shares of common stock vest monthly in each of the 23 months after the date of grant and options to purchase 3,829 shares of common stock will vest on the 24th month anniversary of the date of grant.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
General statement of acquisition of beneficial ownership - Nov. 20, 2017
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017